TOP TIERMARKET NEWSWIRE
Movers explained · September 29, 2026

Why Is NEOGEN CORP (NEOG) Stock Down Today?

By the Top Tier Newswire AI Desk · July 31, 2026 at 12:07 AM ET · reviewed against 4 wire stories

NEOGEN CORP (NEOG) is down -7.22% in the latest session. Our newswire has captured 4 stories on NEOG across 3 sources in the last 36 hours, with AI sentiment reading bearish (avg 40/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

NEOG stock surged 22.66% to $11.53 in early trading on July 30, 2026, driven by the release of strong Q4 fiscal 2026 earnings results and the company’s updated guidance for fiscal 2027. Neogen Corporation reported revenue of $225.3 million for the quarter, exceeding estimates and showing 4.3% core revenue growth, the highest for the year. The company also raised its long-term revenue and adjusted EBITDA outlook for 2027 and reported better-than-expected adjusted earnings per share.

What Happened

Neogen’s Q4 FY2026 earnings call highlighted a strong performance across its core operations. The company reported revenue of $225.3 million, with both its food safety and life sciences segments contributing to the growth. The company also announced adjusted earnings per share of $0.09, surpassing the estimated loss of $0.07. In addition, Neogen outlined FY2027 revenue guidance of $880 million to $885 million and adjusted EBITDA of $180 million to $182 million. These figures represent a significant increase from previous expectations and reflect improved momentum in the business. The company also noted a 50% increase in R&D investment, signaling a strategic focus on innovation and long-term growth.

What The Data Shows

The stock’s performance was supported by strong earnings surprises and optimistic guidance. The company’s Q1 sales guidance of $207 million to $209 million also exceeded estimates of $204.7 million. Despite a recent trailing twelve-month revenue decline of 3.9% and a net margin of -69.9%, the positive earnings beat and forward-looking guidance have sparked investor optimism. The stock closed at $11.53, near its 52-week high of $11.43, suggesting a potential reversal in its recent trend. The market reaction indicates that investors are responding favorably to the company’s operational improvements and strategic direction.

What To Watch

The company’s full FY2027 guidance and ongoing R&D investment will be key to watch in the coming months. Additionally, the regulatory status of Zoetis’ acquisition of Neogen’s genomics business in Australia may impact future operations and market perception.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

NEOG by the numbers

Last: $12.73Session: -7.22%Coverage: 4 stories / 3 sourcesAI sentiment: 40/100 (bearish)Mkt cap: $2.0B52w: $4.56 to $11.43
NEOG · today's session (5-min) · -6.78% vs prior close · updated 3:52 PM ET
$12.73$13.32$13.92prev close $13.72$12.797:10 AM9:20 AM11:30 AM1:40 PM3:50 PM7:10 AM · $13.668:20 AM · $13.648:25 AM · $13.658:30 AM · $13.668:35 AM · $13.729:20 AM · $13.639:25 AM · $13.769:30 AM · $13.789:35 AM · $13.869:40 AM · $13.739:45 AM · $13.649:50 AM · $13.729:55 AM · $13.5710:00 AM · $13.3410:05 AM · $13.0810:10 AM · $13.0410:15 AM · $13.0710:20 AM · $13.0610:25 AM · $13.1510:30 AM · $13.2610:35 AM · $13.3110:40 AM · $13.2510:45 AM · $13.2210:50 AM · $13.1810:55 AM · $13.2911:00 AM · $13.3511:05 AM · $13.3811:10 AM · $13.4311:15 AM · $13.4411:20 AM · $13.1511:25 AM · $13.2111:30 AM · $13.2311:35 AM · $13.2911:40 AM · $13.2811:45 AM · $13.2211:50 AM · $13.1811:55 AM · $13.2012:00 PM · $13.1512:05 PM · $13.1512:10 PM · $13.0412:15 PM · $13.0412:20 PM · $13.0112:25 PM · $13.0612:30 PM · $13.0612:35 PM · $13.0412:40 PM · $12.9712:45 PM · $12.9512:50 PM · $13.0512:55 PM · $13.111:00 PM · $13.141:05 PM · $13.161:10 PM · $13.161:15 PM · $13.151:20 PM · $13.161:25 PM · $13.151:30 PM · $13.091:35 PM · $13.061:40 PM · $13.051:45 PM · $13.041:50 PM · $13.061:55 PM · $13.072:00 PM · $13.092:05 PM · $13.042:10 PM · $12.962:15 PM · $12.972:20 PM · $12.952:25 PM · $12.972:30 PM · $13.092:35 PM · $13.152:40 PM · $13.012:45 PM · $13.022:50 PM · $13.012:55 PM · $13.023:00 PM · $12.953:05 PM · $12.973:10 PM · $13.023:15 PM · $12.983:20 PM · $12.963:25 PM · $12.943:30 PM · $12.813:35 PM · $12.843:40 PM · $12.793:45 PM · $12.853:50 PM · $12.79
AI sentiment, last 36h · averaged over 4 stories · 40/100 bearish
AI sentiment 40/100 (bearish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 4 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agonowSeeking Alpha · sentiment 34 · Neogen gets FDA warning letter over horse deaths linked to HycoatSeeking Alpha · 34Neogen gets FDA warning letter over horse deaths linked to HycoatMorningstar · sentiment 34 · Neogen Gets FDA Warning After Probe Links Vet Product to Horse DeathsMorningstar · 34Neogen Gets FDA Warning After Probe Links Vet Product to Horse DeathsThe Fly · sentiment 34 · Neogen issued FDA warning letter for Neogen Vet HYCOATThe Fly · 34Neogen issued FDA warning letter for Neogen Vet HYCOATThe Fly · sentiment 58 · Neogen selloff after FDA warning letter ‘overdone,’ says GuggenheimThe Fly · 58Neogen selloff after FDA warning letter ‘overdone,’ says Guggenheim
2h agoThe FlyBULLISH 58Analyst

Neogen selloff after FDA warning letter ‘overdone,’ says Guggenheim

2h agoThe FlyBEARISH 34General

Neogen issued FDA warning letter for Neogen Vet HYCOAT

3h agoMorningstarBEARISH 34General

Neogen Gets FDA Warning After Probe Links Vet Product to Horse Deaths

Hycoat is marketed by Neogen as a vet device and is labeled as a sterile topical wound management solution intended for use on surgical wounds, burns and similar conditions. It is packaged in a glass vial with a septum top.

4h agoSeeking AlphaBEARISH 34General

Neogen gets FDA warning letter over horse deaths linked to Hycoat

Neogen (NEOG) shares dip after FDA warning letters over recalled Hycoat linked to horse deaths and contamination.

Frequently asked questions

Why is NEOG stock down today?

NEOGEN CORP (NEOG) is down -7.22% in the latest session. Our newswire has captured 4 stories on NEOG across 3 sources in the last 36 hours, with AI sentiment reading bearish (avg 40/100). The most recent driver: "Neogen selloff after FDA warning letter ‘overdone,’ says Guggenheim" (The Fly).

Is NEOG a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of NEOG coverage reads 40/100 over 4 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.

More moves explained today

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on NEOG: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.